Patents by Inventor Eric Holmgren

Eric Holmgren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230283949
    Abstract: An audio conference system for automatically forming a single combined physical microphone array aperture across associated and/or disassociated ad-hoc microphone elements in a shared 3D space is provided. The audio conference system includes a plurality of microphone/speaker units, each including at least one microphone and/or at least one speaker and a system processor communicating with the microphone/speaker units. The system processor instructs the microphone/speaker units to transmit unique calibration signals sequentially or simultaneously and to calculate time difference of arrival (TDOA) between the microphone/speaker units. A physical array structure of the microphone/speaker units is obtained based on TDOA between the microphone/speaker units, and a consolidated target coverage zone common to the microphone/speaker units is generated based on the physical array structure.
    Type: Application
    Filed: March 2, 2023
    Publication date: September 7, 2023
    Inventors: ALEKSANDER RADISAVLJEVIC, DAVID ERIC HOLMGREN, KAEL BLAIS, ZHENGYIN WANG
  • Publication number: 20230218755
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: March 14, 2023
    Publication date: July 13, 2023
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20210015918
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 25, 2020
    Publication date: January 21, 2021
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20200171148
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: February 4, 2020
    Publication date: June 4, 2020
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20190307881
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: June 25, 2019
    Publication date: October 10, 2019
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20180221473
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 14, 2017
    Publication date: August 9, 2018
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Patent number: 9795672
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: October 24, 2017
    Assignee: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, William Novotny
  • Publication number: 20160310592
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: June 30, 2016
    Publication date: October 27, 2016
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, William NOVOTNY
  • Publication number: 20160304594
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: March 25, 2016
    Publication date: October 20, 2016
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20150359881
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: January 15, 2015
    Publication date: December 17, 2015
    Inventors: Gwendolyn FYFE, Eric HOLMGREN, Robert D. MASS, William NOVOTNY
  • Publication number: 20140178369
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: December 19, 2013
    Publication date: June 26, 2014
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20130195847
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: September 4, 2012
    Publication date: August 1, 2013
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20130028862
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: January 20, 2012
    Publication date: January 31, 2013
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20110123494
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: February 2, 2011
    Publication date: May 26, 2011
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20100226880
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: October 8, 2009
    Publication date: September 9, 2010
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Patent number: 7622115
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: November 24, 2009
    Assignee: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20090246173
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: May 15, 2009
    Publication date: October 1, 2009
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20090191215
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: March 31, 2009
    Publication date: July 30, 2009
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20090053216
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: May 29, 2008
    Publication date: February 26, 2009
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny
  • Publication number: 20090010881
    Abstract: This invention concerns in general treatment of diseases and pathological conditions with anti-VEGF antibodies. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer using an anti-VEGF antibody, preferably in combination with one or more additional anti-tumor therapeutic agents.
    Type: Application
    Filed: June 30, 2008
    Publication date: January 8, 2009
    Applicant: Genentech, Inc.
    Inventors: Gwendolyn Fyfe, Eric Holmgren, Robert D. Mass, William Novotny